middl
east
respiratori
syndrom
coronaviru
merscov
singlestrand
rna
viru
caus
sever
respiratori
diseas
human
high
fatal
rate
bind
receptor
bind
domain
rbd
spike
glycoprotein
dipeptidyl
peptidas
critic
step
merscov
infect
host
cell
vaccin
clinic
applic
treatment
current
avail
merscov
therefor
rapid
diagnosi
import
improv
patient
outcom
prompt
treatment
protect
viral
outbreak
studi
aim
establish
two
elisa
system
detect
antigen
antibodi
merscov
use
recombin
fulllength
protein
indirect
elisa
develop
found
detect
merscovspecif
antibodi
anim
sera
sera
patient
mer
moreov
mab
induc
recombin
protein
rbd
use
sandwich
elisa
detect
merscov
protein
neither
elisa
system
exhibit
signific
intraassay
interassay
variat
indic
good
reproduc
moreov
interday
precis
sensit
adequ
use
diagnost
kit
thu
elisa
use
clinic
diagnos
merscov
confirm
death
report
outbreak
spread
merscov
extrem
rapid
patient
report
may
june
mani
reason
unexpectedli
fast
spread
merscov
korea
includ
late
diagnos
failur
quarantin
super
spreader
famili
caregiv
visit
nondisclosur
patient
poor
commun
korean
govern
inadequ
hospit
infect
manag
doctor
shop
current
approv
therapeut
agent
vaccin
merscov
clinic
use
glycoprotein
known
major
target
neutral
antibodi
viral
infect
rbd
region
merscov
protein
bind
dipeptidyl
peptidas
surfac
host
cell
enabl
infect
cell
merscov
vaccin
develop
therefor
mostli
base
protein
specif
rbd
dna
vaccin
express
fulllength
sequenc
product
advanc
human
trial
thu
rapid
diagnosi
viru
remain
critic
control
spread
diseas
provid
prompt
treatment
current
rtrcr
common
method
diagnos
merscov
major
target
gene
envelop
open
read
frame
nucleocapsid
gene
rtpcr
highli
sensit
specif
howev
timeconsum
provid
viral
titer
serolog
test
detect
antibodi
merscov
elisa
microneutr
immunofluoresc
prnt
assay
also
wide
use
diagnos
merscov
infect
howev
microneutr
immunofluoresc
prnt
assay
base
cell
cultur
therefor
requir
biosafeti
level
contain
studi
aim
establish
specif
antibodi
antigen
develop
elisa
merscov
diagnosi
prepar
two
recombin
protein
one
contain
rbd
alon
one
contain
fulllength
protein
mab
merscov
antigen
use
protein
merscovspecif
antibodi
detect
elisa
mab
merscov
antigen
detect
elisa
final
valid
precis
sensit
reproduc
elisa
sera
patient
mer
use
studi
ethic
approv
institut
review
board
chungnam
nation
univers
hospit
irb
seoul
nation
univers
hospit
irb
studi
perform
accord
ethic
standard
laid
declar
helsinki
subsequ
revis
patient
provid
written
inform
consent
particip
merscov
protein
prepar
bactobac
baculoviru
express
system
invitrogen
carlsbad
ca
usa
merscov
gene
genbank
access
clone
vector
transfer
bacmid
vector
transposit
baculoviru
obtain
transfect
vector
cell
deriv
insect
spodoptera
frugiperda
prepar
baculovirus
use
infect
cell
moi
harvest
day
cell
pellet
separ
supernat
via
centrifug
g
min
lyse
lysi
buffer
cell
membran
contain
merscov
protein
obtain
differenti
centrifug
ultracentrifug
solubl
membran
extract
purifi
anion
exchang
chromatographi
glucos
affin
chromatographi
protein
concentr
ultrafiltr
analyz
sdspage
coomassi
blue
stain
pgemrid
vector
use
express
rbd
express
vector
compos
rid
aa
ntermin
mous
lyr
protein
nonspecif
transfer
rna
interact
domain
rbd
fragment
aa
prepar
gene
merscov
pcr
insert
kpni
sali
site
vector
plasmid
transform
e
coli
strain
star
plyss
cultur
overnight
ml
lb
medium
contain
mgml
ampicillin
mgml
chloramphenicol
ml
cultur
broth
use
inocul
ml
lb
medium
incub
od
reach
protein
express
induc
ad
mm
iptg
cell
centrifug
g
min
od
cell
lysat
obtain
sonic
centrifug
g
min
separ
solubl
fraction
pellet
fraction
protein
purifi
use
histrap
hp
column
ge
healthcar
marlborough
usa
equilibr
column
wash
buffer
protein
obtain
linear
gradient
imidazol
elut
buffer
concentr
centriprep
millipor
billerica
usa
analyz
sdspage
indirect
sandwich
elisa
merscov
coomassi
blue
stain
purifi
sampl
quantifi
use
known
concentr
bsa
amresco
solon
oh
usa
control
product
polyclon
antibodi
merscov
protein
protein
mg
use
immun
wistar
rat
n
daehan
bio
link
chungbuk
korea
twice
interv
three
week
second
immun
rat
kill
human
accord
offici
protocol
polyclon
antibodi
sera
harvest
previous
report
method
anim
experi
perform
accord
relev
ethic
guidelin
regul
establish
korean
associ
laboratori
anim
rat
hous
specificpathogenfre
condit
standard
hr
lightdark
cycl
maintain
accord
protocol
approv
institut
anim
care
use
committe
chonbuk
nation
univers
mous
mab
merscov
rbd
protein
produc
atgen
seoul
korea
use
previous
report
protocol
brief
mg
antigen
inject
sc
balbc
mice
boost
mg
antigen
interv
splenocyt
obtain
day
last
immun
fuse
fo
myeloma
cell
gener
hybridoma
cell
cultur
supernat
hybridoma
cell
screen
presenc
antigenspecif
antibodi
elisa
use
merscov
rbd
protein
coat
antigen
hybridoma
cell
specif
react
antigen
select
subclon
limit
dilut
method
mab
cell
cultur
supernat
purifi
protein
g
column
ge
healthcar
accord
manufactur
instruct
indirect
elisa
method
develop
measur
merscovspecif
antibodi
elisa
plate
coat
overnight
mgwell
merscov
protein
human
sera
plate
wash
pbst
tween
pb
three
time
incub
hr
block
solut
bsa
pb
four
wash
serum
sampl
dilut
bsa
pb
ad
well
plate
incub
hr
three
wash
hrpconjug
goat
antihuman
immunoglobulin
g
dilut
bsa
contain
pb
ad
plate
follow
incub
hr
plate
wash
five
time
tetramethylbenzidin
solut
ad
min
n
h
ad
stop
reaction
od
measur
micropl
reader
except
use
secondari
antibodi
dilut
invitrogen
specif
bind
igg
fc
rat
rabbit
incub
anim
serum
sampl
procedur
follow
rat
rabbit
sera
sandwich
elisa
method
establish
quantifi
merscov
protein
determin
detector
captur
antibodi
mab
rbd
protein
evalu
pairwis
test
detector
antibodi
biotinyl
dialysi
hr
three
time
ngml
biotin
solut
elisa
plate
coat
overnight
mgwell
captur
antibodi
plate
wash
pbst
three
time
incub
hr
block
solut
bsa
pb
four
wash
antigen
sampl
dilut
bsa
pb
ad
well
plate
incub
hr
wash
biotinyl
detector
antibodi
ad
plate
follow
incub
hr
three
wash
avidinhrp
dilut
bsa
contain
pb
ad
plate
follow
incub
min
plate
wash
five
time
tetramethylbenzidin
solut
ad
min
n
h
ad
stop
reaction
od
measur
micropl
reader
purifi
protein
load
onto
formvarco
grid
min
grid
neg
stain
uranyl
acet
dri
aspir
protein
observ
tecnai
spirit
transmiss
electron
microscop
fei
hillsboro
usa
oper
kv
imag
digit
obtain
ccd
camera
k
k
resolut
fulllength
mer
protein
express
recombin
baculoviru
system
harvest
infect
insect
cell
purifi
chromatographi
purifi
merscov
protein
analyz
sdspage
result
identif
major
band
molecular
weight
kda
fig
electron
microscop
particl
nm
diamet
observ
fig
size
similar
previous
report
rbd
express
fusion
mrid
e
coli
improv
protein
solubl
fold
previous
report
mridrbd
protein
molecular
weight
kda
express
pellet
fraction
iptg
induct
fig
amount
protein
sampl
calcul
base
band
intens
bsa
control
fig
heatinactiv
merscovimmun
rabbit
polyclon
antibodi
purchas
joongkyeom
ansan
korea
polyclon
antibodi
use
determin
whether
merscov
protein
produc
studi
specif
bind
merscovimmun
serum
addit
merscov
proteinimmun
rat
polyclon
antibodi
produc
studi
test
merscov
protein
use
coat
antigen
indirect
elisa
detect
merscovspecif
antibodi
anim
sera
protein
coat
concentr
ngwell
anim
sera
heatinactiv
merscovimmun
rabbit
sera
proteinimmun
rat
sera
also
serial
dilut
twice
protein
bound
specif
dilut
serum
fig
indic
recombin
protein
produc
studi
could
use
develop
diagnost
system
merscov
specif
detect
antibodi
merscov
patient
serum
use
mer
protein
mention
recombin
protein
specif
bind
merscovderiv
proteinderiv
antibodi
rat
rabbit
sera
next
whether
protein
use
diagnos
merscov
infect
patient
sera
determin
analysi
whether
recombin
protein
abl
specif
bind
sera
patient
mer
investig
two
independ
hospit
patient
diagnos
mer
realtim
rtpcr
target
upe
perform
korean
center
diseas
control
laboratori
hospit
use
protocol
dilut
patient
sera
one
dilut
patient
sera
ratio
twice
n
fig
wherea
dilut
patient
sera
ratio
twice
n
fig
step
rest
elisa
protocol
incub
time
detail
materi
method
ng
protein
use
coat
well
normal
human
serum
use
neg
control
titer
antibodi
merscov
protein
sera
patient
mer
measur
indirect
elisa
differ
dilut
fig
elisa
titer
significantli
higher
neg
control
even
serum
dilut
patient
sera
one
hospit
fig
howev
four
five
sera
examin
hospit
exhibit
higher
elisa
titer
five
neg
control
dilut
fig
possibl
fifth
patient
extrem
low
merscov
antibodi
titer
thu
patient
serum
dilut
elisa
success
distinguish
sera
patient
mer
healthi
human
serum
indic
recombin
mer
protein
produc
studi
specif
bind
merscovderiv
antibodi
human
sampl
develop
assay
use
clinic
diagnos
merscov
infect
develop
sandwich
elisa
detect
merscov
protein
mab
specif
bind
merscov
protein
first
produc
character
atgen
develop
mab
protein
mab
rbd
select
captur
detector
antibodi
pairwis
test
perform
mab
elisa
use
mgml
detector
mgml
captur
antibodi
fig
shown
figur
c
two
combin
abl
detect
ng
protein
mab
captur
antibodi
rbd
mab
detector
rbd
mab
captur
antibodi
mab
detector
howev
combin
combin
specif
bound
serial
dilut
protein
fig
thu
combin
mab
induc
protein
baculoviru
system
detector
antibodi
mab
induc
rbd
e
coli
system
captur
antibodi
determin
optim
pair
develop
sandwich
elisa
assess
sandwich
elisa
develop
studi
amount
intraassay
variat
withinrun
precis
interassay
variat
betweenrun
precis
determin
confirm
good
linear
reproduc
intraand
interassay
r
valu
coeffici
variat
cv
fig
b
interday
precis
test
assess
differ
test
run
two
time
point
day
apart
show
compar
r
valu
vs
cv
valu
fig
theoret
lld
sandwich
elisa
ngml
merscov
protein
fig
mention
indirect
elisa
detect
merscovinduc
antibodi
anim
human
patient
sera
develop
coat
well
ng
mer
protein
twelv
mab
deriv
protein
test
protein
select
standard
antibodi
among
mab
show
best
perform
serial
dilut
mab
exhibit
bind
activ
ng
protein
data
shown
therefor
mab
use
valid
indirect
elisa
intraassay
interassay
variat
show
r
valu
respect
indic
good
linear
moreov
cv
valu
indic
good
reproduc
fig
b
test
interday
precis
differ
two
time
point
show
similar
r
cv
valu
indic
accept
reproduc
interv
fig
sensit
lld
ngml
merscovspecif
antibodi
fig
although
mer
caus
acut
respiratori
diseas
repres
consider
threat
current
approv
vaccin
drug
condit
fast
accur
diagnosi
therefor
promis
mean
control
mer
outbreak
tradit
prnt
andor
microneutr
test
use
gold
standard
detect
merscovspecif
antibodi
howev
test
laborintens
timeconsum
requir
highlevel
biosafeti
facil
involv
handl
live
virus
therefor
conveni
method
requir
recent
celisa
label
mab
compet
test
serum
antibodi
target
epitop
develop
compar
prnt
assay
pearson
correl
coeffici
reportedli
depend
celisa
serum
dilut
although
correl
posit
consider
variat
prnt
titer
present
studi
develop
two
elisa
system
indirect
elisa
detect
merscovinduc
antibodi
sandwich
elisa
detect
merscov
protein
express
merscov
protein
rbd
recombin
baculoviru
e
coli
system
respect
indirect
elisa
involv
coat
recombin
fulllength
protein
specif
bound
antibodi
mer
patient
sera
show
good
linear
reproduc
well
high
precis
sensit
therefor
indirect
elisa
develop
studi
use
clinic
detect
mersspecif
antibodi
patient
sera
addit
use
serial
dilut
proteinimmun
rat
sera
compar
indirect
elisa
titer
prnt
titer
human
sera
use
insuffici
volum
patient
sera
avail
howev
find
posit
correl
two
titer
differ
sensit
two
assay
specif
dilut
merscov
antibodi
still
show
high
titer
indirect
elisa
wherea
detect
prnt
assay
data
shown
note
also
possibl
neutral
antibodi
rat
serum
sampl
therefor
state
previou
report
studi
necessari
develop
celisa
use
merscov
proteinderiv
mab
order
determin
correl
celisa
prnt
latter
current
use
clinic
diagnos
merscov
infect
studi
establish
sandwich
elisa
detect
merscov
protein
use
mab
induc
protein
rbd
valid
assay
recombin
protein
demonstr
good
reproduc
precis
sensit
therefor
although
test
whether
recombin
spike
proteininduc
mab
detect
authent
merscov
sandwich
elisa
use
clinic
detect
presenc
merscov
biolog
sampl
patient
suspect
mer
variou
contamin
materi
recent
studi
shown
qrtpcr
also
accur
detect
merscov
genom
varieti
biolog
sampl
even
extrem
small
amount
viru
moreov
biolog
hazard
level
requir
devic
facil
capabl
perform
sandwich
elisa
realtim
pcr
similar
thu
sandwich
elisa
offer
signific
advantag
realtim
pcr
clinic
set
howev
sandwich
elisa
develop
studi
directli
detect
quantifi
merscov
protein
given
merscov
vaccin
candid
target
protein
promis
vaccin
target
sandwich
elisa
could
use
qualitycontrol
test
measur
antigen
content
vaccin
candid
rather
detect
merscov
clinic
set
conclus
develop
indirect
sandwich
elisa
detect
merscovinduc
antibodi
protein
respect
elisa
adequ
reproduc
precis
sensit
clinic
use
howev
intens
test
assay
sera
patient
requir
